If you do not have an account, please create one by clicking the 'Create account' button above.
TANL 2018 Conference: Thrombosis in Every Day Clinical Practice
Location: Faculty of Medicine & via WebEx, St. John's
Date: 22 September 2018
Description
ONLINE REGISTRATION IS NOW CLOSED. IF YOU WOULD LIKE TO ATTEND THE CONFERENCE, PLEASE REGISTER ONSITE AT THE FACULTY OF MEDICINE ATRIUM, SATURDAY, SEPT 22, 7:30AM.
TANL Conference 2018 is a half day continuing professional development (CPD) event focusing on issues pertaining to thrombosis and anticoagulation management in Newfoundland & Labrador.
The Keynote speaker is Dr. Marc Carrier, an Associate Professor in the Faculty of Medicine, University of Ottawa, and a scientist in the clinical epidemiology program of the Ottawa Hospital Research Institute. Dr. Carrier holds a Tier 2 Research Chair in Venous Thromboembolism and Cancer from the University of Ottawa and a New Investigator Award from the Heart and Stroke Foundation of Canada. He is a recognized leader in the field of cancer associated thrombosis.
This CPD accredited event is available to attend in person or via webinar. Early Bird Registration closes on July 31, 2018.
OVERALL TANL Conference Learning Objectives:
- Answer multiple practical every day thrombosis questions faced in clinical practice*
- Select an appropriate new/direct oral anticoagulant for a patient
- Describe the updated management of cancer associated thrombosis in clinical practice
- Determine appropriate antiplatelet therapy in patients with coronary artery disease and peripheral arterial disease
- Demonstrate the pharmacist’s role in providing an outpatient thrombosis service
*Interactive session: Rapid-Fire Questions are everyday questions that may not usually be addressed in a full talk but affect daily clinical practice. 1-3 slides per question, and the audience will choose questions they are most interested in during the talk. Examples: From a venous thromboembolism perspective, is my patient safe to fly? How do I advise on alcohol and anticoagulation?
Learning Objectives
At the end of this program, participants will be able to:
- Review the risk and benefits of Dual and Triple Therapy
- Identify the right Direct Oral Anti-coagulant (DOAC) for the right patient
- Discuss the collaborative practice of clinical pharmacists in the Eastern Health Adult Outpatient Thrombosis Service
- Illustrate the practice of pharmacists in this setting using cased based examples
- Employ evidence-based practical every day clinical decisions regarding prevention and treatment of venous thromboembolism and/or atrial fibrillation
- Employ evidence-based practical every day clinical decisions regarding management of the complications of venous thromboembolism
- Provide an overview of treatment of coronary artery disease and non-valvular atrial fibrillation
- Assess the role of the direct oral anticoagulants and antiplatelet therapy in stable CV disease
- Discuss the role of New/Direct Oral Anti-coagulants for treatment and prevention of cancer associated thrombosis
- Identify screening for cancer in patients with VTE
- Describe the management of Incidental PE in cancer patients
- Describe the indications for reduced dose Direct Oral Anti-coagulant (DOAC) Therapy for VTE and Afib
- Discuss an update on reversal of the DOACs
- Explain the effect of body weight on DOAC Therapy
Program Agenda
Saturday, September 22, 2018 | |
---|---|
7:30 AM |
Registration, Continental Breakfast, & Networking |
8:00 AM |
Welcome Presenter: Dr. Rufaro Chitsike |
8:05 AM |
Antiplatelet and Anticoagulant Therapy for Acute Coronary Syndrome and Stable Cardiovascular Disease Presenter: Dr. Mohammad Almutawa |
8:50 AM |
An Update in Cancer Associated Thrombosis Presenter: Dr. Marc Carrier |
9:50 AM |
Nutrition Break & Networking |
10:30 AM |
An Update on the New (Directed) Oral Anticoagulants Presenter: Dr. Marc Carrier |
11:30 AM |
Practicing at Full Scope and Creating a Novel Footprint: Pharmacist Practice in the Eastern Health Outpatient Thrombosis Service Presenter: Dr. Kristi Parmiter |
11:55 AM |
Rapid Fire Questions in Thrombosis & Anticoagulation (audience chosen questions) and Open Questions Presenter: Dr. Rufaro Chitsike Presenter: Dr. Stephanie Young Presenter: Dr. Jacqueline Costello Presenter: Dr. Marc Carrier |
12:55 PM |
Closing & Departure Presenter: Dr. Stephanie Young |
Planning Committee
- Rufaro Chitsike, MD, MMed Haem, FCPath(Haem), Cert Clin(Haem)
Hematologist, Eastern Health
Assistant Professor, Medicine
Faculty of Medicine, MUN - Percy Crocker, MD, CCFP, FCFP
General Practice
Eleven Elizabeth Family Practice, St. John's - Anusree Subramonian, MBBS, MSc (c) Clinical Epidemiology
Research Assistant (Hematology)
Faculty of Medicine, MUN - Cindy Whitton, MEd, BBA, AIT
Operations Manager
Professional Development and Conferencing Services
Faculty of Medicine, Memorial University, St. John's, NL - Stephanie Young, BSc (Pharm), ACPR, Pharm.D., MSc(Med)
Associate Professor
School of Pharmacy, MUN
Faculty
- Mohammad Almutawa, MD, FRCPC
Interventional Cardiologist
Division of Cardiology
Eastern Health - Marc Carrier, MD, MSc, FRCPC
Professor, Faculty of Medicine, University of OttawaSenior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research InstituteVice Chair of Research, Department of MedicineProgram Director, Thrombosis Fellowship - Rufaro Chitsike, MD, MMed Haem, FCPath(Haem), Cert Clin(Haem)
Hematologist, Eastern Health
Assistant Professor, Medicine
Faculty of Medicine, MUN - Jacqueline Costello, MD, FRCPC
Hematologist, Eastern Health
Clinical Assistant Professor, Medicine
Faculty of Medicine, MUN - Kristi Parmiter, BScPharm, PharmD
Clinical Assistant Professor
School of Pharmacy, MUN - Stephanie Young, BSc (Pharm), ACPR, Pharm.D., MSc(Med)
Associate Professor
School of Pharmacy, MUN
Accreditation Review
- RCPSC Review - Jennifer R. Leonard, MD, FRCPC
Associate Professor of Medicine (Gastroenterology)
Faculty of Medicine, MUN - CFPC Review - Pamela Snow, MD, CCFP, FCFP Associate Professor of Family MedicineDirector of PatoFaculty of Medicine, MUN
Parking
Lot 30
Acknowledgements
Funds in support of this CME activity were provided as an educational grant to Memorial University. The funds were independently allocated and disbursed in accordance with current CMA guidelines. An educational grant to help support this program provided by:
Bayer
Sanofi
Pfizer
Novartis
Servier
Roche Diagnostics